This document summarizes a presentation on validation given by Prajakta Sawant, a first year M.Pharm student at Alard College of Pharmacy in Pune, India. The presentation covered the need for validation, types of validation including process, cleaning, equipment and analytical method validation. It discussed validation concepts such as the validation master plan, documentation, and ICH and WHO guidelines. The goal of validation is to ensure consistent production of pharmaceuticals meeting quality standards.
M.pharm (Pharmaceutics) modern pharmacy unit-5 Study of consolidation parameters; Diffusion parameters, Dissolution
parameters and Pharmacokinetic parameters, Heckel plots, Similarity factors – f2
and f1, Higuchi and Peppas plot, Linearity Concept of significance, Standard
deviation , Chi square test, students T-test , ANOVA test
M.pharm (Pharmaceutics) modern pharmacy unit-5 Study of consolidation parameters; Diffusion parameters, Dissolution
parameters and Pharmacokinetic parameters, Heckel plots, Similarity factors – f2
and f1, Higuchi and Peppas plot, Linearity Concept of significance, Standard
deviation , Chi square test, students T-test , ANOVA test
This presentation includes the detail information about the physics of tablet compression and compaction, Compression, Effect of friction, distribution of forces, compaction profiles,solubility.
This presentation includes introduction of validation, types of validation,process validation of dosage forms[ solids(tablets),liquids(emulsions and suspensions),semisolids.
DATION OF EQUIPMENT ICH AND WHO GUIDELINES FOR CALIBRATION AND VALIDATION OF ...deepalisanap31
Introduction to equipment
Calibration
ICH guidelines for calibration of equipment
WHO guidelines for calibration of equipment
Example for calibration of UV
Validation
ICH guidelines for validation of equipment
WHO guidelines for validation of equipment
Example for validation of tablet compression machine
Objectives and policies of c gmp, layout of building and servicesSharwari Sapate
Pharmaceutical Quality affects every individual. Therefore GMP is required to ensure the quality of the particular drug or dosage form. In this presentation you will go through some basic information about cGMP and layout of buildings.
It is the documented act of proving that any procedure, process, equipment, material, activity or system actually leads to the expected result.
It is the confirmation by examination and the provision of objective evidence that the particular requirements for a specific intended use are fulfilled.
This presentation includes the detail information about the physics of tablet compression and compaction, Compression, Effect of friction, distribution of forces, compaction profiles,solubility.
This presentation includes introduction of validation, types of validation,process validation of dosage forms[ solids(tablets),liquids(emulsions and suspensions),semisolids.
DATION OF EQUIPMENT ICH AND WHO GUIDELINES FOR CALIBRATION AND VALIDATION OF ...deepalisanap31
Introduction to equipment
Calibration
ICH guidelines for calibration of equipment
WHO guidelines for calibration of equipment
Example for calibration of UV
Validation
ICH guidelines for validation of equipment
WHO guidelines for validation of equipment
Example for validation of tablet compression machine
Objectives and policies of c gmp, layout of building and servicesSharwari Sapate
Pharmaceutical Quality affects every individual. Therefore GMP is required to ensure the quality of the particular drug or dosage form. In this presentation you will go through some basic information about cGMP and layout of buildings.
It is the documented act of proving that any procedure, process, equipment, material, activity or system actually leads to the expected result.
It is the confirmation by examination and the provision of objective evidence that the particular requirements for a specific intended use are fulfilled.
A brief introduction of validation concept, its scope, advantage. Types of validation, stages of validation, Consideration in principle of validation. Prerequisites of validation, validation protocol, process validation, strategy of process validation of solid dosage form, validation report.
Analytical method validation.
validation is an important documentation protocol used in most of the laboratories and industries which is used for validation and evaluating different research protocols and equipment used in product formulation and development
Qualification and Validation have big Weightage in the Regulatory Compliance and GMP. Qualification and Validation only can guarantee about the Product Safety, Integrity, Strength, Purity and Quality assurance.
Validation.
Validation is establishing documented evidence which provides a high degree of assurances that a specific process or equipment will consistently produce a product or result meeting its predetermined specifications and quality attributes”.
A system must be qualified to operate in a validated process
The results of analytical procedures should be:
— reliable
— accurate
— reproducible
The characteristics that should be considered during validation of analytical methods are:
— specificity
— linearity
— range
— accuracy
— precision
— detection limit
— quantitation limit
— robustness
Similar to Validation (intro, scope, merits, ich, who guidelines) (20)
Formulation Building blocks: Building blocks for different product formulatio...PRAJAKTASAWANT33
Building blocks for different product formulations of
cosmetics/cosmeceuticals. Surfactants - Classification and application. Emollients,
rheological additives: classification and application.
Biopharmaceutic considerations in drug product design and In Vitro Drug Produ...PRAJAKTASAWANT33
Introduction, biopharmaceutic factors affecting drug bioavailability, rate–limiting steps in drug absorption, physicochemical nature of the drug formulation factors affecting drug product performance
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Validation (intro, scope, merits, ich, who guidelines)
1. Presented By:
Ms. Prajakta Sawant
First Year M.Pharm (Roll No. 5)
(Dept. of Pharmaceutics)
Sub: Modern Pharmaceutics
Alard College Of Pharmacy,
Pune.
Under the Guidance of:
Dr. Nalanda Borkar
Head of Department
(Dept. of Pharmaceutics)
Sub: Modern Pharmaceutics
Alard College Of Pharmacy,
Pune.
Monday, March 08, 2021 1
2. Introduction
Need of Validation
Planning for Validation
Documentation of Validation
Validation Master Plan
Scope of Validation
V Model for Validation
Merits of Validation
Types of Validation
⇨ Process Validation
⇨ Cleaning Validation
⇨ Equipment Validation
⇨Validation of Analytical method
Conclusion for Validation
ICH Guidelines
WHO Guidelines
References
Monday, March 08, 2021 2
3. The concept of validation was first proposed by Food and Drug
Administration (FDA) officials, Ted Byers and Bud Loftus, in
the mid 1970s in order to improve the quality of
pharmaceuticals.
Validation is "Establishing documented evidence that provides
a high degree of assurance that a specific process will
consistently produce a product meeting its pre-determined
specifications and quality attributes."
This is to maintain and assure a higher degree of quality of
food and drug products.
Monday, March 08, 2021 3
4. Customer satisfaction
Customer mandated
Product liability
Control production cost
The development of the next generation
Safety
Monday, March 08, 2021 4
5. Validation activities can be organized by preparing the
validation master plan (VMP). It should be brief, concise and
clear.
The EEC guide recommends the following contents in a VMP.
Validation Policy Organizational structure of validation
activities.
Summary of facilities, systems, equipment and processes to be
validated.
Documentation format Planning and scheduling Change
control reference to exiting documents.
Monday, March 08, 2021 5
6. The validation activity cannot be completed without proper
documentation of each and every minute activity with utmost
details. Documentation of validation is generally of different
types such as:
Validation Master Plan(VMP)
Validation Protocol(VP)
Validation Reports(VR)
Standard Operating Procedure(SOP)
Monday, March 08, 2021 6
7. A Validation Master Plan is a document that summarizes the firm’s
overall philosophy, intention and approaches to be used for
establishing performance adequacy.
A tool to track progress.
Assignment of responsibility and team work.
It identifies acceptance criteria before the start of validation.
V.M.P gives idea about future performance:
What activities are to be performed?
Who is going to perform these activities?
When the activities should start and when they should get over?
What documents will be generated?
What the policy on revalidation?
Monday, March 08, 2021 7
8. V.M.P. includes:
Premises
Processes
Products
Format for protocol and other documentation
List of relevant SOPs
Planning and scheduling
Location
Estimation of staffing requirements
A time plan of the project
Monday, March 08, 2021 8
9. Guidelines on Preparing V.M.P.
V.M.P. write on A4 size paper.
File in a presentable form.
Have sufficient explanatory drawings.
Clearly divide the V.M.P. in different form.
It must be dated and signed properly by authorized persons.
If found any step inappropriate, discuss this with the F.D.A.
people in advance.
Relationship between validation and qualification:
Qualification and validation are essentially the same. The term
qualification is normally used for equipment and utilities, and
validation is for systems and processes. In this sense,
qualification can be seen as a part of validation.
Monday, March 08, 2021 9
10. Selection of raw material i.e. raw materials of desired quality attributes.
Product design based on the expected performance.
Process design to build the desired quality attributes in the product.
Design of control parameters, such as change control, acceptance criteria,
tolerance limits, etc.
In process quality control parameters and sampling plans
Finished product testing or evaluation criteria.
Validation of related analytical process.
Validation of related system, facility and equipment.
Personnel training.
Validation involves careful determination of criteria variable of the
process, such as moisture content of granules, drying temperature of time,
etc. and then establishment of acceptable range and tolerance limit for the
same. A careful and continuous control of these variables will ensure
consistent product quality.
Monday, March 08, 2021 10
12. URS, FAT and SAT:
User Requirement Specifications- Manufacturers should prepare a
document that describes, for example, the utility or equipment to
be sourced. The requirements and specifications for the utility or
equipment should be defined by the user and should be
documented in the URS.
Factory Acceptance Test and Site Acceptance Test- Where
appropriate, FAT and SAT should be performed to verify the
suitability of the system at site, prior to the subsequent stages of
qualification. This should be appropriately documented.
Monday, March 08, 2021 12
13. Assurance of quality compliance.
Optimization of resources and manufacture product at lowest
possible cost.
Fewer failures, fewer rejects, fewer retests, fewer reworks,
fewer wastage.
It is a practice that must be followed for manufacturing,
distribution, selling or license.
Efficient production operation.
Monday, March 08, 2021 13
14. The major types of Validation :
Process validation
Cleaning validation
Equipment validation
Validation of analytical methods
Monday, March 08, 2021 14
15. As per FDA, the Process Validation is defined as :
"The collection of data from the process design
stage throughout production, which establishes
scientific evidence that a process is capable of
consistently delivering quality products. "
Monday, March 08, 2021 15
16. Process validation life cycle/flow chart:
Stage 1 - Process design
Stage 2 - Process qualification
Stage 3 - Continued process verification
Monday, March 08, 2021 16
17. Types of Process validation:
Prospective validation.
Retrospective validation.
Concurrent validation.
Revalidation.
Monday, March 08, 2021 17
18. 1. Prospective validation
Establishing documented evidences during
development stage of process based on a
predefined protocol.
It is done prior to distribution of a new product or
whenever there is a major change in the product
characteristics.
It is compulsory for sterile products.
The activity continues till the first 3 batches are
manufactured at full scale.
Monday, March 08, 2021 18
19. Steps in prospective validation:
1. Formation of validation team
2. Preparation of validation master plan and validation protocol
3. Formulation development (preformulation studies and optimization)
4. Process development (process design, control & challenges in critical
parameters etc.)
5. Facility development (building, support systems, staff)
6. Process qualification (checked for worst case conditions o ensure
reproducibility)
7. Product qualification
8. Change control
Monday, March 08, 2021 19
20. 2. Concurrent Process validation
Carried out during normal production.
It is useful only if process is well understood during development stage.
The nature and specifications of subsequent in- process and final tests are
based on the evaluation of the results of such monitoring.
3. Retrospective process validation (based on analysis of historical data)
Carried out on the basis of database generated during previous production
of the product.
Recorded difficulties, variation and failures in production are analysed to
determine the limits of process parameters.
Thus, it is useful in establishing priorities for validation.
Monday, March 08, 2021 20
21. 4. Revalidation
It is needed to ensure that the changes in process or
in process environment do not adversely affect the
process characteristic and product quality.
Revalidation is required when:-
a) There is a major change in facility, equipment,
process, etc.
b) Periodic revalidation is scheduled at regular
interval to control and identify a gradual change in
the process.
Monday, March 08, 2021 21
22. Definition: “A process of attaining and documenting sufficient
evidence to give reasonable assurance, given the current state of
Science and Technology, that the cleaning process under
consideration does, and / or will do, what it purpose is to do.”
Objective:
To minimize cross contamination.
To determine efficiency of cleaning process.
To do troubleshooting in case if problem is identified in the cleaning
process and give suggestions to improve the process.
Monday, March 08, 2021 22
23. Source of contamination:
Cross contamination of one product into another.
Product contamination by a foreign material.
Microbial contamination.
Cleaning methods:
Manual cleaning method.
Semi automated procedures.
Fully automated procedures.
Monday, March 08, 2021 23
26. Definition : As per FDA, "Action of proving that any equipment
works correctly and leads to the expected result is equipment
validation. It is not a single step activity but instead result from
many discrete activities. "
Steps involved:
User requirement specification
Design qualification
Installation qualifications
Operational qualifications
Performance qualification
Monday, March 08, 2021 26
28. Definition : “The process by, which it is established, by laboratory
studies, that the performance characteristics of the method meet
the requirements for the intended analytical application”.
Accuracy : The closeness of test results obtained by that method to
the true value. This accuracy should be established across its range.
Precision: The degree of agreement among individual test results
when the method is applied repeatedly to multiple sampling of a
homogenous sample.
Monday, March 08, 2021 28
29. Specificity : The ability to assess unequivocally the analyte in the
presence of components that may be expected to be present, such
as impurities, degradation products and matrix components.
Limit of Quantitation : A characteristic of quantitative assays for
low levels of compounds in sample matrices such as impurities in
bulk substances and degradation products in finished
pharmaceuticals. It is the lowest amount of analyte in a sample
that can be determined with acceptable precision and accuracy
under the stated experimental conditions.
Monday, March 08, 2021 29
30. Range : Interval between the upper and lower of analyte
(including these levels) that have been demonstrated to be
determined with a suitable level of precision , accuracy and
linearity using the method as written. The range is normally
expressed in the same units as test results obtained by the
analytical method ( e.g. Percentage , parts per million, etc.).
Ruggedness: The degree of reproducibility of test results
obtained by the analysis of the same sample under a variety of
conditions such as different laboratories, different analysts,
different instruments, different lots of reagents, different elapsed
assay times, different assay temperatures, different days, etc.
Monday, March 08, 2021 30
31. Robustness: A measure of its capacity to remain unaffected by small
but deliberate variations in method parameters and provides an
indication of its reliability during normal usage.
Linearity : Its ability to elicit tests that are directly or by a well defined
mathematical transformations proportional to the concentration of
analyte in samples within a given range.
Limit of Detection : The lowest amount of analyte in a sample that can
be detected but not necessarily quantitated, under the stated
experimental conditions.
Monday, March 08, 2021 31
32. Validation has been proven assurance for the process efficiency
and sturdiness and it is the full fledged quality attributing tool
for the pharmaceutical industries.
Validation is the commonest word in the areas of drug
development, manufacturing and specification of finished
products. It also renders reduction in the cost linked with
process monitoring, sampling and testing.
Apart from all the consistency and reliability of a validated
process to produce a quality product, it is very important for an
industry.
Monday, March 08, 2021 32
33. The International Conference on Harmonization of Technical
Requirements for Registration of Pharmaceuticals for Human
Use (ICH) is a unique project that brings together the
regulatory authorities of Europe, Japan and the United States
and experts from the pharmaceutical industry in the three
regions to discuss scientific and technical aspects of product
registration.
Monday, March 08, 2021 33
34. AIM :
The International Conference on Harmonization of Technical
Requirements for the Registration of Pharmaceuticals for Human
Use (ICH) was established in 1990 as a joint regulatory/industry
project to improve, through harmonization, the efficiency of the
process for developing and registering new medicinal products in
Europe, Japan and the United States, in order to make these
products available to patients with a minimum of delay.
The six parties to ICH represent the regulatory and research-
based industry in the three regions, Europe, Japan and the USA,
where the vast majority of new medicines are currently
developed.
Monday, March 08, 2021 34
35. European Commission - European Union (EU).
European Federation of Pharmaceutical Industries and
Associations (EFPIA).
Ministry of Health, Labour and Welfare, Japan (MHLW).
Japan Pharmaceutical Manufacturers Association (JPMA).
US Food and Drug Administration (FDA).
Pharmaceutical Research and Manufacturers of America
(PhRMA).
Monday, March 08, 2021 35
36. More economical use of human, animal, and
material resources.
Elimination of unnecessary delay in the global
development & availability of new medicines.
Maintaining safeguards on Quality, safety, efficacy
and regulatory obligations to protect public health.
Monday, March 08, 2021 36
37. Four Broad Categories - QSEM
1) Quality (Q): those relating to chemical and pharmaceutical
Quality Assurance (Stability Testing, Impurity Testing,
etc.)
2) Safety (S): those relating to in vitro and in vivo pre-clinical
studies (Carcinogenicity Testing, Genotoxicity Testing,
etc.)
3) Efficacy (E): those relating to clinical studies in human
subject (Dose Response Studies, Good Clinical Practices,
etc.)
4) Multidisciplinary (M): cross-cutting Topics which do not
fit uniquely into one of the above categories (MedDRA,
ESTRI, M3, CTD, M5)
Monday, March 08, 2021 37
38. QUALITY:
Q1A(R2): STABILITY TESTING OF NEW DRUGS AND PRODUCTS
Q1B: PHOTOSTABILITY TESTING
Q1C : STABILITY TESTING OF NEW DOSAGE FORMS
Q1D: BRACKETING AND MATRIXING DESIGNS FOR STABILITY TESTING
OF DRUG SUBSTANCES AND DRUG PRODUCTS.
Q1E: EVALUATION OF STABILITY DATA
Q1F: STABILITY DATA PACKAGE FOR REGISTRATION IN CLIMATIC ZONES
III AND IV
Q2A: DEFINTIONS AND TERMINOLOGY: ANALYTICAL VALIDATION
Q2B: METHODOLOGY
Q3A(R2) : IMPURITIES IN NEW DRUG SUBSTANCES Q3B(R2) : IMPURITIES
IN NEW DRUG PRODUCT
Q3C(R3) : IMPURITIES GUIDELINES FOR RESIDUAL SOLVENTS
Monday, March 08, 2021 38
39. Q4: PHARMACOPOEIA
Q4A: PHARMACOPOEIAL HARMONIZATION
Q5A: VIRAL SAFETY EVALUATION
Q5B: GENETIC STABILITY
Q5C: STABILITY OF BIOTECHNOLOGY PRODUCTS
Q5D: CELL SUBSTRATES 12
Q6A: SPECIFICATIONS, TEST PROCEDURES AND ACCEPTANCE
CRITERIA FOR NEW DRUG SUBSTANCES AND PRODUCTS
Q6B : SPECIFICATION TEST PROCEDURE AND ACCEPTANCE
CRITRIA FOR BIOTECHNOLOGICAL/ BIOLOGICAL PRODUCTS
Q7A: GMP FOR ACTIVE PHARMACEUTICAL INGREDIENTS
Q8: PHARMACEUTICAL DEVELOPMENT
Q9: QUALITY RISK MANAGEMENT
Q10: PHARMACEUTICAL QUALITY SYSTEM
Monday, March 08, 2021 39
40. SAFETY :
S1A: GUIDELINE ON THE NEED FOR CARCINOGENICITY
STUDIES OF PHARMACEUTICALS
S1B: TESTING FOR CARCINOGENICITY OF
PHARMACEUTICALS
S1C(R2): DOSE SELECTION FOR CARCINOGENICITY STUDIES
OF PHARMACEUTICALS
S2(R1): GUIDANCE ON GENOTOXICITY TESTING AND DATA
INTERPRETATION FOR PHARMACEUTICALS INTENDED FOR
HUMAN USE
S3A: NOTE FOR GUIDANCE ON TOXICOKINETICS: THE
ASSESSMENT OF SYSTEMIC EXPOSURE IN TOXICITY STUDIES
S3B: PHARMACOKINETICS:GUIDANCE FOR REPEATED DOSE
TISSUE DISTRIBUTION STUDIES
S4: DURATION OF CHRONIC TOXICITY TESTING IN ANIMALS
(RODENT AND NON RODENT TOXICITY TESTING)
Monday, March 08, 2021 40
41. S5(R2): DETECTION OF TOXICITY TO REPRODUCTION FOR
MEDICINAL PRODUCTS & TOXICITY TO MALE FERTILITY
S6(R1): ADDENDUM TO ICH S6: PRECLINICAL SAFETY
EVALUATION OF BIOTECHNOLOGY-DERIVED PHARMACEUTICALS
S6: PRECLINICAL SAFETY EVALUATION OF BIOTECHNOLOGY-
DERIVED PHARMACEUTICALS
S7A: SAFETY PHARMACOLOGY STUDIES FOR HUMAN
PHARMACEUTICALS
S7B: THE NON-CLINICAL EVALUATION OF THE POTENTIAL FOR
DELAYED VENTRICULAR REPOLARIZATION (QT INTERVAL
PROLONGATION) BY HUMAN PHARMACEUTICALS
S8: IMMUNOTOXICITY STUDIES FOR HUMAN PHARMACEUTICALS
S9: NONCLINICAL EVALUATION FOR ANTICANCER
PHARMACEUTICALS
Monday, March 08, 2021 41
42. 3) EFFICACY:
E1: THE EXTENT OF POPULATION EXPOSURE TO ASSESS CLINICAL
SAFETY
E2A: CLINICAL SAFETY DATA MANAGEMENT
E2B(R2): MAINTENANCE OF THE ICH GUIDELINE ON CLINICAL
SAFETY DATA MANAGEMENT
E2B(R3): REVISION OF THE ICH GUIDELINE ON CLINICAL SAFETY
DATA MANAGEMENT
DATA ELEMENTS FOR TRANSMISSION OF INDIVIDUAL CASE
SAFETY REPORTS
E2C(R1): CLINICAL SAFETY DATA MANAGEMENT: PERIODIC
SAFETY UPDATE REPORTS FOR MARKETED DRUGS
E2D: POST-APPROVAL SAFETY DATA MANAGEMENT: DEFINITIONS
AND STANDARDS FOR EXPEDITED REPORTING
Monday, March 08, 2021 42
43. E2E: PHARMACOVIGILANCE PLANNING
E2F: DEVELOPMENT SAFETY UPDATE REPORT
E3: STRUCTURE AND CONTENT OF CLINICAL STUDY
REPORTS
E4: DOSE-RESPONSE INFORMATION TO SUPPORT DRUG
REGISTRATION
E5(R1): ETHNIC FACTORS IN THE ACCEPTABILITY OF
FOREIGN CLINICAL DATA
E6(R1): GUIDELINE FOR GOOD CLINICAL PRACTICE
E7: STUDIES IN SUPPORT OF SPECIAL
POPULATIONS:GERIATRICS 19
E8: GENERAL CONSIDERATIONS FOR CLINICAL TRIALS
Monday, March 08, 2021 43
44. MULTIDISCIPLINARY GUIDELINES:
M1- MedDRA : Medical Terminology
M2- ESTRI: Electronic Standards for the Transfer of
Regulatory Information
M3- (R2): Nonclinical Safety Studies for the Conduct of
Human Clinical Trials and Marketing Authorization for
Pharmaceuticals
M4- CTD: The Common Technical Document
M5 : Data Elements and Standards for Drug Dictionaries
Monday, March 08, 2021 45
45. These guidelines focus mainly on the overall concept of validation
and are not intended to be prescriptive in specific validation
requirements.
This document serves as general guidance only and the principles
may be considered useful in its application in the manufacture and
control of starting materials and finished pharmaceutical products
(FPPs), as well as other areas.
Validation of specific processes and systems, for example, in sterile
product manufacture, requires much more consideration and a
detailed approach that is beyond the scope of this document.
Monday, March 08, 2021 46
46. The definitions given below apply to the terms used in these guidelines. They may
have different meanings in other contexts.
Calibration
The set of operations that establish, under specified conditions, the relationship
between values indicated by an instrument or system for measuring (for example,
weight, temperature and pH), recording, and controlling, or the values represented
by a material measure, and the corresponding known values of a reference
standard. Limits for acceptance of the results of measuring should be established.
Computer
Validation Documented evidence which provides a high degree of assurance that a
computerized system analyses, controls and records data correctly and that data
processing complies with predetermined specifications.
Commissioning
The setting up, adjustment and testing of equipment or a system to ensure that it
meets all the requirements, as specified in the user requirement specification, and
capacities as specified by the designer or developer. Commissioning is carried out
before qualification and validation.
Monday, March 08, 2021 47
48. Good Engineering Practices (GEP) :Established engineering methods and
standards that are applied throughout the project life-cycle to deliver
appropriate, cost-effective solutions.
Qualification: Action of proving and documenting that any premises,
systems and equipment are properly installed, and/or work correctly and lead
to the expected results. Qualification is often a part (the initial stage) of
validation, but the individual qualification steps alone do not constitute
process validation.
Standard operating procedure (SOP): An authorized written procedure
giving instructions for performing operations not necessarily specific to a
given product or material but of a more general nature (e.g. equipment
operation, maintenance and cleaning; validation; cleaning of premises and
environmental control; sampling and inspection). Certain SOPs may be used
to supplement product-specific master batch production documentation.
Monday, March 08, 2021 49
49. Validation Protocol (or plan) (VP): A document describing the
activities to be performed in a validation, including the acceptance
criteria for the approval of a manufacturing process or a part thereof for
routine use.
Validation Report (VR): A document in which the records, results and
evaluation of a completed validation programme are assembled and
summarized. It may also contain proposals for the improvement of
processes and/or equipment.
Verification: The application of methods, procedures, tests and other
evaluations, in addition to monitoring, to determine compliance with
the GMP principles.
Worst Case: A condition or set of conditions encompassing the upper
and lower processing limits for operating parameters and
circumstances, within SOPs, which pose the greatest chance of product
or process failure when compared to ideal conditions. Such conditions
do not necessarily include product or process failure.
Monday, March 08, 2021 50
50. Periodic revalidation:
• Periodic revalidation should be performed to assess process changes that may
occur gradually over a period of time, or because of wear of equipment.
• The following should be considered when periodic revalidation is performed:
master formulae and specifications; SOPs; records (e.g. of calibration,
maintenance and cleaning); and analytical methods.
Revalidation after change:
• Revalidation should be performed following a change that could have an
effect on the process, procedure, quality of the product and/or the product
characteristics.
• Revalidation should be considered as part of the change control procedure.
• The extent of revalidation will depend on the nature and significance of the
change(s).
• Changes should not adversely affect product quality or process
characteristics.
• Changes requiring revalidation should be defined in the validation plan.
Monday, March 08, 2021 51
51. CHANGE CONTROL:
• Changes should be controlled in accordance with a SOP as changes may
have an impact on a qualified utility, system or piece of equipment, and a
validated process and/or procedure.
• The procedure should describe the actions to be taken, including the need
for and extent of qualification or validation to be done.
• Changes should be formally requested, documented and approved before
implementation. Records should be maintained.
PERSONNEL:
• Personnel should demonstrate that they are appropriately qualified,
where relevant.
• Personnel requiring qualification include, for example:
— laboratory analysts;
— personnel following critical procedures;
— personnel doing data entry in computerized systems; and
— risk assessors.
Monday, March 08, 2021 52